Skip to article
Astra

Psychiatry

Panic Disorder

Evaluate acute cardiopulmonary, respiratory, toxicologic, and substance-related mimics before diagnosing panic disorder. Confirm recurrent unexpected attacks plus persistent concern or avoidance, then select disorder-focused CBT, an SSRI or SNRI, or both according to severity, preference, access, and comorbidity.

Clinical question: How should clinicians exclude dangerous mimics, confirm panic disorder, and choose evidence-supported treatment?

Emergency assessment

Do not diagnose panic disorder before excluding acute medical illness

Stabilize and investigate according to the presenting symptom complex rather than attributing chest pain or dyspnea to anxiety.

For an acute episode with chest discomfort, dyspnea, wheeze, syncope, or marked autonomic symptoms, perform a focused cardiopulmonary and substance-exposure assessment before making a psychiatric diagnosis. Emergency evaluation may include point-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry to identify respiratory abnormalities; obtain toxicology screening when drug misuse or intoxication is plausible. PubMedClinical Practice Guidelines for Assessment and Management of ...

A panic attack has abrupt onset, peaks within 10 minutes, and is characterized by at least 4 physical or cognitive symptoms; an episode commonly lasts about 1 hour. This temporal pattern supports, but does not establish, a panic diagnosis because acute medical disorders can present with similar symptoms. PubMedClinical Practice Guidelines for Assessment and Management of ...

After acute physical causes have been evaluated, document the event phenotype, triggers, frequency, avoidance, current medications, and substance use. A symptom score can quantify burden but cannot replace medical exclusion or longitudinal diagnostic assessment. PubMedClinical Practice Guidelines for Assessment and Management of ...

Acute branches that determine the next diagnostic action. PubMedClinical Practice Guidelines for Assessment and Management of ...
Presentation patternImmediate diagnostic actionInterpretation and next step
Dyspnea, wheeze, or suspected respiratory abnormalityPoint-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry. PubMedClinical Practice Guidelines for Assessment and Management of ...Treat or further evaluate identified respiratory disease; diagnose panic disorder only after physical causes are addressed. PubMedClinical Practice Guidelines for Assessment and Management of ...
Symptoms with possible substance exposureToxicology screening. PubMedClinical Practice Guidelines for Assessment and Management of ...If exposure is identified, assess a substance- or medication-related cause before assigning primary panic disorder. PubMedClinical Practice Guidelines for Assessment and Management of ...
Abrupt fear with autonomic and cognitive symptomsCharacterize onset, peak, symptom count, recurrence, and post-attack behavior. PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMCRapid peak supports a panic attack phenotype; recurrent unexpected attacks plus persistent sequelae are required for panic disorder. PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC

Longitudinal diagnosis

Confirm panic disorder and separate agoraphobic avoidance

The diagnostic pivot is recurrence of unexpected attacks followed by durable concern or behavior change.

Diagnose panic disorder when recurrent unexpected panic attacks are accompanied by at least 1 month of persistent concern, worry, or behavioral change related to attacks. The post-attack persistence requirement distinguishes a recurrent disorder from an isolated panic attack. PubMedPanic Disorder: Current Research and Management Approaches - PMC

Assess agoraphobia separately. DSM-5 distinguishes agoraphobia from panic disorder, so document avoidance and its functional effect rather than treating agoraphobic behavior as automatically establishing panic disorder. PubMedPanic Disorder: Current Research and Management Approaches - PMC

Measure baseline severity with the Panic Disorder Severity Scale, Panic Disorder Self-Report, Panic and Agoraphobia Scale, NIMH Panic Questionnaire, or Panic-Associated Symptoms Scale. The Panic Disorder Severity Scale is among tools identified for physician use in emergency and primary-care settings. PubMedClinical Practice Guidelines for Assessment and Management of ...

Diagnostic elements that change classification and management. PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC
FindingClinical interpretationAction
Single or recurrent episodes without documented 1-month sequelaeA panic attack phenotype may be present, but the persistence criterion for panic disorder is not established. PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMCContinue medical and longitudinal assessment; avoid prematurely labeling panic disorder. PubMedPanic Disorder: Current Research and Management Approaches - PMC
Recurrent unexpected attacks plus ≥1 month of worry, concern, or behavioral changeMeets the operational DSM-5 description of panic disorder. PubMedPanic Disorder: Current Research and Management Approaches - PMCEstablish severity baseline and initiate disorder-focused treatment. PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC
Avoidance consistent with agoraphobiaAgoraphobia is distinguished from panic disorder in DSM-5. PubMedPanic Disorder: Current Research and Management Approaches - PMCDocument separately and incorporate avoidance-focused treatment goals. PubMedPanic Disorder: Current Research and Management Approaches - PMC

Definitive treatment

Choose CBT, first-line antidepressant therapy, or both

Select treatment by patient preference, access, symptom burden, avoidance, comorbidity, and prior treatment response.

Offer cognitive behavioral therapy as an evidence-based treatment pathway. In a systematic review and meta-analysis of 69 randomized trials involving 4,118 outpatients with anxiety-related disorders, CBT was associated with better panic-disorder outcomes than control conditions after treatment and at 1 to 6 months and 6 to 12 months of follow-up; reported Hedges g values for panic disorder were 0.22 to 0.35. JAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and

When medication is chosen, use an SSRI or SNRI as first-line pharmacotherapy. An umbrella review of antipsychotic agents in anxiety disorders reports that treatment guidelines recommend SSRIs or SNRIs first line, whereas benzodiazepines, TCAs, and other agents are not first-line pharmacotherapy. WileyAntipsychotic agents in anxiety disorders: An umbrella review

For patients preferring psychodynamic treatment or unable to engage in CBT, panic-focused psychodynamic psychotherapy has randomized-trial evidence versus applied relaxation training, but its comparative effectiveness against CBT and medications remains unresolved. NEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician Do not substitute an untested modality for CBT or a first-line antidepressant without clarifying that evidence limitation.

Treatment-selection framework for confirmed panic disorder. JAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review andNEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM ClinicianWileyAntipsychotic agents in anxiety disorders: An umbrella review
Clinical situationPreferred next stepKey tradeoff
Patient prefers psychotherapy or has a strong avoidance targetOffer CBT. JAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review andCBT showed benefit versus control conditions through 6 to 12 months after treatment completion. JAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and
Patient prefers medication or requires pharmacotherapyStart an SSRI or SNRI as first-line pharmacotherapy. WileyAntipsychotic agents in anxiety disorders: An umbrella reviewMonitor response and tolerability before moving to non-first-line medication classes. WileyAntipsychotic agents in anxiety disorders: An umbrella review
CBT is unavailable, unacceptable, or not feasibleDiscuss panic-focused psychodynamic psychotherapy as an alternative. NEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM ClinicianEvidence exists versus applied relaxation training, but comparative evidence against CBT and medications is still needed. NEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician
Considering antipsychotic, benzodiazepine, or TCA as initial treatmentReassess the treatment plan; these are not identified as first-line pharmacotherapy in guideline summaries. WileyAntipsychotic agents in anxiety disorders: An umbrella reviewReserve non-first-line approaches for individualized circumstances rather than routine initial management. WileyAntipsychotic agents in anxiety disorders: An umbrella review

Avoid reflexive antipsychotic use

Do not use an antipsychotic as routine first-line pharmacotherapy for panic disorder. Guideline recommendations summarized in an umbrella review place SSRIs and SNRIs first line and classify benzodiazepines, TCAs, and other agents outside that first-line position. WileyAntipsychotic agents in anxiety disorders: An umbrella review

Follow-up

Measure response and reassess the diagnosis before changing treatment

Track attack burden, anticipatory anxiety, avoidance, function, adverse effects, adherence, and alternative explanations at each treatment decision.

Use the same structured measure at baseline and follow-up when possible, particularly the Panic Disorder Severity Scale or a panic-specific self-report instrument. This makes change in panic frequency, symptom burden, and agoraphobic avoidance visible rather than relying solely on an unstructured global impression. PubMedClinical Practice Guidelines for Assessment and Management of ...

When response is inadequate, first reassess adherence, diagnostic accuracy, and comorbidities before changing therapy. Across adult depression guidelines, this sequence was a common initial recommendation for inadequate first-line treatment and is a useful safeguard against premature medication switching in patients with persistent panic-like symptoms. BMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open

Reopen the medical differential when the symptom pattern changes, new cardiopulmonary or respiratory findings emerge, or substance exposure becomes plausible. Repeat targeted evaluation rather than attributing all subsequent episodes to a prior panic diagnosis. PubMedClinical Practice Guidelines for Assessment and Management of ...

Follow-up decisions after treatment initiation. BMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ OpenPubMedClinical Practice Guidelines for Assessment and Management of ...
Follow-up findingNext actionReason
Improvement on baseline panic measureContinue the effective treatment plan and continue structured symptom monitoring. PubMedClinical Practice Guidelines for Assessment and Management of ...A panic-specific tool provides a reproducible measure of change. PubMedClinical Practice Guidelines for Assessment and Management of ...
Persistent symptoms with uncertain adherence, diagnosis, or comorbidityAssess adherence, reassess diagnosis, and evaluate comorbidities before changing first-line treatment. BMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ OpenThese were common first steps across reviewed inadequate-response guidelines. BMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open
New or changed dyspnea, chest, respiratory, or substance-related featuresRepeat targeted acute medical evaluation, including respiratory testing or toxicology screening when indicated. PubMedClinical Practice Guidelines for Assessment and Management of ...Physical and substance-related causes require reassessment before psychiatric attribution. PubMedClinical Practice Guidelines for Assessment and Management of ...

References

  1. [PDF] NDA 215455 - FDAwww.fda.gov · www.fda.gov
  2. [PDF] Prozac (fluoxetine hydrochloride) 10 mg, 20 ... - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  3. Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Openbmjopen.bmj.com · bmjopen.bmj.com
  4. Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review andjamanetwork.com · jamanetwork.com
  5. Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analysesbmjopen.bmj.com · bmjopen.bmj.com
  6. Psychodynamic Psychotherapy for Panic Disorder? | NEJM Clinicianclinician.nejm.org · clinician.nejm.org
  7. Screening for Anxiety in Adolescent and Adult Women - ACP Journalswww.acpjournals.org · www.acpjournals.org
  8. Management of Chronic Insomnia Disorder in Adults - ACP Journalswww.acpjournals.org · www.acpjournals.org
  9. The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  10. Couple therapy and systemic interventions for adult‐focused ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  11. Panic Disorder and Migraine: Comorbidity, Mechanisms, and ...headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
  12. The identification and psychological treatment of panic disorder in ...acamh.onlinelibrary.wiley.com · acamh.onlinelibrary.wiley.com
  13. Antipsychotic agents in anxiety disorders: An umbrella reviewonlinelibrary.wiley.com · onlinelibrary.wiley.com
  14. A Network Analysis of Panic Disorder, Agoraphobia, and ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  15. Evaluating the efficacy of psychological therapies for generalised ...acamh.onlinelibrary.wiley.com · acamh.onlinelibrary.wiley.com
  16. Diagnosis and treatment of patients with bipolar disorderonlinelibrary.wiley.com · onlinelibrary.wiley.com
  17. Cardiac Anxiety - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  18. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  19. Table A4, Characteristics of Included Guidelines - Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  20. Table 1, Current clinical practice guidelines for the treatment of child and adolescent DDs - Treatment of Depression in Children and Adolescents: A Systematic Review - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  21. Table 4, Characteristics of Included Guidelines - Short-Term Psychodynamic Psychotherapy for the Treatment of Mental Illness: A Review of Clinical Effectiveness and Guidelines - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents - PMCwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  23. Clinical Practice Guidelines for Assessment and Management of ...pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Panic Disorder: Current Research and Management Approaches - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov